Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | DGKA | P23743 | 1/20 | 0.47 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.47 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4205589 | 0.98 | CNR1 (0.52) | CNR1ALDH1A1MAPK1L3MBTL1DGKA | |
| SCHEMBL4214273 | 0.98 | CNR1 (0.52) | CNR1ALDH1A1MAPK1L3MBTL1DGKA | |
| SCHEMBL28348314 | 0.98 | CNR1 (0.52) | CNR1ALDH1A1MAPK1L3MBTL1DGKA | |
| SCHEMBL4214982 | 0.98 | CNR1 (0.52) | CNR1ALDH1A1MAPK1L3MBTL1DGKA | |
| SCHEMBL4220980 | 0.98 | CNR1 (0.52) | CNR1ALDH1A1MAPK1L3MBTL1DGKA | |
| SCHEMBL4214279 | 0.98 | CNR1 (0.52) | CNR1ALDH1A1MAPK1L3MBTL1DGKA | |
| SCHEMBL4210164 | 0.98 | CNR1 (0.52) | CNR1ALDH1A1MAPK1L3MBTL1DGKA | |
| SCHEMBL7500299 | 0.95 | ALDH1A1 (0.50) | ALDH1A1MAPK1L3MBTL1KMT2AFFAR1 | |
| SCHEMBL18381104 | 0.94 | ALDH1A1 (0.54) | ALDH1A1MAPK1L3MBTL1KMT2AFFAR1 | |
| SCHEMBL18381100 | 0.92 | ALDH1A1 (0.53) | ALDH1A1MAPK1L3MBTL1KMT2AFFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4865648-A | ELECTRON DONOR DYE; ESTER; PHENOL, CARBOXY ACID, PHOSPHATE ESTER, TRIAZOLE | KITO TSUTOMU (JP) | 1989-09-12 | — | — | US | claimed |
| US-4720301-A | Reversible heat sensitive recording composition | PILOT INK CO., LTD. (JP) | 1988-01-19 | — | — | US | claimed |
| US-11225100-B2 | Tunable directional color transition compositions and methods of making and using the same | SEGAN INDUSTRIES, INC. (US) | 2022-01-18 | — | — | US | disclosed |
| EP-2969582-B1 | COMPOUNDS FOR REDUCING BACKGROUND COLOR IN COLOR CHANGE COMPOSITIONS | SEGAN IND INC (US) | 2021-06-02 | — | — | EP | disclosed |
| US-10709818-B2 | Modified alginates for anti-fibrotic materials and applications | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2020-07-14 | — | — | US | disclosed |
| CN-111272304-A | Lower critical temperature indicator | 苏州和萃新材料有限公司 | 2020-06-12 | — | — | CN | disclosed |
| US-10570294-B2 | Compounds for reducing background color in color change compositions | SEGAN INDUSTRIES, INC. (US) | 2020-02-25 | — | — | US | disclosed |
| US-20190204280-A1 | Tunable Directional Color Transition Compositions and Methods of Making and Using the Same | SEGAN INDUSTRIES, INC. | 2019-07-04 | — | — | US | disclosed |
| US-20190142713-A1 | Optical Evanescent Color Change Compositions and Methods of Making and Using the Same | SEGAN INDUSTRIES, INC. | 2019-05-16 | — | — | US | disclosed |
| EP-3443042-A1 | OPTICAL EVANESCENT COLOR CHANGE COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME | Segan Industries, Inc. (US) | 2019-02-20 | — | — | EP | disclosed |
| US-10168307-B1 | Tunable directional color transition compositions and methods of making and using the same | SEGAN INDUSTRIES, INC. (US) | 2019-01-01 | — | — | US | disclosed |
| EP-2969582-A1 | COMPOUNDS FOR REDUCING BACKGROUND COLOR IN COLOR CHANGE COMPOSITIONS | Segan Industries, Inc. (US) | 2016-01-20 | — | — | EP | disclosed |
| US-9217736-B2 | Tunable directional color transition compositions and methods of making and using the same | SEGAN INDUSTRIES, INC. (US) | 2015-12-22 | — | — | US | disclosed |
| US-20140275381-A1 | COMPOUNDS FOR REDUCING BACKGROUND COLOR IN COLOR CHANGE COMPOSITIONS | SEGAN INDUSTRIES, INC. | 2014-09-18 | — | — | US | disclosed |
| WO-2014144693-A1 | COMPOUNDS FOR REDUCING BACKGROUND COLOR IN COLOR CHANGE COMPOSITIONS | SEGAN INDUSTRIES, INC. (US) | 2014-09-18 | — | — | WO | disclosed |
| US-8569208-B1 | Tunable directional color transition compositions and methods of making and using the same | SEGAN INDUSTRIES, INC. (US) | 2013-10-29 | — | — | US | disclosed |
| US-6165234-A | FOR IMPARTING REVERSIBLE COLOR CHANGES TO WAXES AND CANDLES WHEN HEATED OR WHEN WAX MELTS OR WHEN THE CANDLE BURNS | KANAKKANATT SEBASTIAN V (US) | 2000-12-26 | — | — | US | disclosed |
| CN-1132756-A | Antiviral ethers of aspartate protease substrate isosteres | CIBA GEIGY AG (CH) | 1996-10-09 | — | — | CN | disclosed |
| US-4865648-A | ELECTRON DONOR DYE; ESTER; PHENOL, CARBOXY ACID, PHOSPHATE ESTER, TRIAZOLE | KITO TSUTOMU (JP) | 1989-09-12 | — | — | US | disclosed |
| US-4720301-A | Reversible heat sensitive recording composition | PILOT INK CO., LTD. (JP) | 1988-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10709818-B2 | Modified alginates for anti-fibrotic materials and applications | ALG1, FIBP, COL2A1 | CNR1 4251/4885ALDH1A1 337/4885MAPK1 4705/4885 |
| US-20190142713-A1 | Optical Evanescent Color Change Compositions and Methods of Making and Using the Same | ERCC1, XPA, ERCC5 | CNR1 2214/4885ALDH1A1 1999/4885MAPK1 4031/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.